Pesenti A, Pelosi P, Rossi N, Aprigliano M, Brazzi L, Fumagalli R
Department of Anesthesia and Intensive Care, University of Milan, San Gerardo Hospital, Monza (MI), Italy.
Crit Care Med. 1993 Jan;21(1):78-83. doi: 10.1097/00003246-199301000-00016.
To study the effects of salbutamol (a selective beta 2-adrenergic receptor agonist) on respiratory mechanics in patients with the adult respiratory distress syndrome (ARDS).
Prospective study.
ICU in a university hospital.
Seven mechanically ventilated, paralyzed ARDS patients.
Measurements of respiratory system compliance, maximum, and minimum inspiratory resistance (by the end-inspiratory occlusion method during constant flow inflation) were performed at 0, 5, 10 cm H2O positive end-expiratory pressure, both before and at least 30 mins after the start of a continuous iv infusion of salbutamol (15 micrograms/min). Minimum inspiratory resistance represents the ohmic air flow resistance, while maximum inspiratory resistance includes minimum inspiratory resistance plus the effective additional resistance due to stress adaptation and to time constant inhomogeneities. Air flow was measured at the airway connector and tracheal pressure near the central end of the artificial airway.
Maximum inspiratory resistance, minimum inspiratory resistance, and additional resistance were higher than the values reported for normal anesthetized subjects. On average, salbutamol caused a decrease in maximum and minimum inspiratory resistances (from 6.48 +/- 2.56 to 4.67 +/- 1.74 and from 4.06 +/- 2.12 to 2.07 +/- 0.95 cm H2O/L/sec, respectively). Positive end-expiratory pressure increased additional resistance, whereas it decreased minimum inspiratory resistance. No interaction was found between positive end-expiratory pressure and salbutamol. Respiratory system compliance was not significantly affected by salbutamol nor by positive end-expiratory pressure.
In ARDS patients, salbutamol decreases the abnormally high airway resistance, by reducing minimum resistance, but has no effect on the effective additional resistance.
研究沙丁胺醇(一种选择性β2肾上腺素能受体激动剂)对成人呼吸窘迫综合征(ARDS)患者呼吸力学的影响。
前瞻性研究。
大学医院的重症监护病房。
7例接受机械通气、麻痹的ARDS患者。
在呼气末正压为0、5、10 cmH2O时,于持续静脉输注沙丁胺醇(15微克/分钟)开始前及开始后至少30分钟,通过恒流充气时吸气末阻断法测量呼吸系统顺应性、最大和最小吸气阻力。最小吸气阻力代表欧姆气流阻力,而最大吸气阻力包括最小吸气阻力加上因应力适应和时间常数不均匀性导致的有效附加阻力。在气道连接器处测量气流,并在人工气道中心端附近测量气管压力。
最大吸气阻力、最小吸气阻力和附加阻力高于正常麻醉受试者报告的值。平均而言,沙丁胺醇使最大和最小吸气阻力降低(分别从6.48±2.56降至4.67±1.74以及从4.06±2.12降至2.07±0.95 cmH2O/L/秒)。呼气末正压增加附加阻力,而降低最小吸气阻力。未发现呼气末正压与沙丁胺醇之间存在相互作用。沙丁胺醇和呼气末正压均未显著影响呼吸系统顺应性。
在ARDS患者中,沙丁胺醇通过降低最小阻力降低异常高的气道阻力,但对有效附加阻力无影响。